The defense launch demand behind Rocket Lab stock’s run was visible in the company’s own contract announcements months before the market paid for it.
Rocket Lab (RKLB) stock has climbed about 88% over the past year, against 23% for the S&P 500 and 39% for defense peer LMT. That looks like a market waking up to something new. It was not. The demand that drove the run was announced contract by contract, in the company’s own releases and results updates, well before the price followed.
The Thread Started With A Hypersonic Testing Contract
Go back to the company’s full-year 2024 results, reported in February 2025, months before the run began. Rocket Lab had just been selected by Kratos to support the next phase of the Department of Defense’s MACH-TB program, a $1.45 billion five-year effort to expand hypersonic technology testing. The vehicle that flies that work is HASTE, the suborbital variant of its Electron rocket. That was a signed program, not an ambition, and it named where the next leg of launch demand would come from.
Defense Missions Scaled, Constellation Orders Doubled
By the company’s own account in May 2025, both the U.S. and the United Kingdom had picked HASTE for their hypersonic programs, including a spot on a multi-awardee U.S. Air Force contracting vehicle with a shared $46 billion ceiling, and seven HASTE missions were booked under MACH-TB. On the commercial side the earth-imaging operator iQPS had already doubled its Electron order from four launches to eight, and Rocket Lab flew the fifth of those just before the run began. Repeat orders from a defense buyer and a constellation buyer are the least glamorous evidence in a space story, and the most durable.
Options Were Priced For Calm, The Ride Was Not
The options market was not braced for it either. Implied volatility on Rocket Lab options sat in the 34th percentile of its trailing one-year range in June 2025, and the 31st percentile five weeks later, meaning traders were positioned for a smaller move than usual in either direction. The payoff did not arrive in a straight line: from a starting price of $44.1 the stock touched $150.23 over the trailing 52 weeks and sits at $82.83 now. The fall from that high needs a far larger gain to undo, which is the arithmetic the Trefis High Quality Portfolio is built around.
Readable In Advance, Just Not The Path
So were the signs real? What came later settles it. The thread that began with a hypersonic testing program ran on into a record $266 million multi-launch missile defense contract with the U.S. Space Force in July 2026, the largest launch contract Rocket Lab has signed, securing $266 million in long-term value for a company that reported $200.3 million in fiscal Q1 2026 revenue. Backlog had reached roughly $2.2 billion in the same quarter, and by late July 2026 iQPS had placed a third multi-launch Electron booking in under a year. What none of that could tell you was the path. A rising outlook shows up in the backlog before it shows up in the price, which is exactly what a screen for rising outlooks meeting price momentum is built to find.